Cargando…

Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery

To optimize gene delivery to myelinating Schwann cells we compared clinically relevant AAV serotypes and injection routes. AAV9 and AAVrh10 vectors expressing either EGFP or the neuropathy-associated gene GJB1/Connexin32 (Cx32) under a myelin specific promoter were injected intrathecally or intraven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kagiava, A., Richter, J., Tryfonos, C., Leal-Julià, M., Sargiannidou, I., Christodoulou, C., Bosch, A., Kleopa, K. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640002/ https://www.ncbi.nlm.nih.gov/pubmed/34857831 http://dx.doi.org/10.1038/s41598-021-02694-1

Ejemplares similares

AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy
por: Kagiava, Alexia, et al.
Publicado: (2021)

Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse
por: Schuster, Daniel J., et al.
Publicado: (2014)

Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs
por: Mullagulova, Aysilu, et al.
Publicado: (2023)

Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
por: Stavrou, Marina, et al.
Publicado: (2021)

Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy
por: Schiza, Natasa, et al.
Publicado: (2019)

Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy
por: Kagiava, Alexia, et al.
Publicado: (2023)

Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors
por: Horiuchi, Makoto, et al.
Publicado: (2022)

Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors
por: Horiuchi, Makoto, et al.
Publicado: (2022)

Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease
por: Olympiou, Margarita, et al.
Publicado: (2016)

Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
por: Belur, Lalitha R., et al.
Publicado: (2020)

Aberrant Mitochondrial Dynamics and Exacerbated Response to Neuroinflammation in a Novel Mouse Model of CMT2A
por: Stavropoulos, Filippos, et al.
Publicado: (2021)

A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice
por: Stavrou, Marina, et al.
Publicado: (2022)

Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration
por: Hinderer, Christian, et al.
Publicado: (2020)

Global CNS Gene Delivery and Evasion of Anti-AAV Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates
por: Gray, Steven J., et al.
Publicado: (2013)

Cellular and Tissue Selectivity of AAV Serotypes for Gene Delivery to Chondrocytes and Cartilage
por: Yoon, Dong Suk, et al.
Publicado: (2021)

Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE
por: Stavropoulos, Filippos, et al.
Publicado: (2021)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
por: Issa, Shaza S., et al.
Publicado: (2023)

Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
por: Gilkes, J.A., et al.
Publicado: (2015)

Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection
por: Hammond, Sean L., et al.
Publicado: (2017)

Thermal Stability as a Determinant of AAV Serotype Identity
por: Bennett, Antonette, et al.
Publicado: (2017)

Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes
por: Nass, Shelley A., et al.
Publicado: (2017)

Novel GJA1/Cx43 Variant Associated With Oculo-Dento-Digital Dysplasia Syndrome: Clinical Phenotype and Cellular Mechanisms
por: Sargiannidou, Irene, et al.
Publicado: (2021)

Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy
por: Bailey, Rachel M., et al.
Publicado: (2018)

Molecular epidemiology of enteroviruses in Cyprus 2008-2017
por: Richter, Jan, et al.
Publicado: (2019)

Intravenous rAAV2/9 injection for murine cochlear gene delivery
por: Shibata, Seiji B., et al.
Publicado: (2017)

Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5
por: Schuster, Daniel J., et al.
Publicado: (2014)

Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9
por: Jan, Asad, et al.
Publicado: (2019)

Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor
por: Pillay, Sirika, et al.
Publicado: (2017)

Targeted Gene Delivery to the Enteric Nervous System Using AAV: A Comparison Across Serotypes and Capsid Mutants
por: Benskey, Matthew J, et al.
Publicado: (2015)

Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid
por: Goertsen, David, et al.
Publicado: (2022)

Switching of serotype can improve local AAV-mediated gene therapy in RA
por: Adriaansen, J, et al.
Publicado: (2004)

Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle
por: Pacak, Christina A, et al.
Publicado: (2008)

Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery
por: Chahal, Parminder Singh, et al.
Publicado: (2014)

In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans
por: Schwartz, Maura K., et al.
Publicado: (2023)

Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A
por: Klamroth, Robert, et al.
Publicado: (2022)

Altered Expression of Glial Gap Junction Proteins Cx43, Cx30, and Cx47 in the 5XFAD Model of Alzheimer’s Disease
por: Angeli, Stella, et al.
Publicado: (2020)

Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver
por: Huang, Wei, et al.
Publicado: (2017)

Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion
por: Castle, Michael J., et al.
Publicado: (2018)

Glial Gap Junction Pathology in the Spinal Cord of the 5xFAD Mouse Model of Early-Onset Alzheimer’s Disease
por: Pechlivanidou, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9rgubv0h767nint825gkncj4o